Tanya Wallace, Ph. - Publications


32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Crane A, Brubaker WD, Johansson JU, Trigunaite A, Ceballos J, Bradt B, Glavis-Bloom C, Wallace TL, Tenner AJ, Rogers J. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to Aβ immunotherapy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28755839 DOI: 10.1016/j.jalz.2017.04.015  0.6
2017 Brubaker WD, Crane A, Johansson JU, Yen K, Garfinkel K, Mastroeni D, Asok P, Bradt B, Sabbagh M, Wallace TL, Glavis-Bloom C, Tenner AJ, Rogers J. Peripheral complement interactions with amyloid β peptides in Alzheimer's disease: Erythrocyte clearance of amyloid β peptides. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28475854 DOI: 10.1016/j.jalz.2017.03.010  0.6
2015 Wallace TL, Bertrand D. Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia. International Review of Neurobiology. 124: 79-111. PMID 26472526 DOI: 10.1016/bs.irn.2015.08.003  0.6
2015 Goonawardena AV, Heiss J, Glavis-Bloom C, Trube G, Borroni E, Alberati D, Wallace TL. Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26354045 DOI: 10.1038/npp.2015.281  0.6
2015 Wallace TL, Ballard TM, Glavis-Bloom C. Animal paradigms to assess cognition with translation to humans. Handbook of Experimental Pharmacology. 228: 27-57. PMID 25977079 DOI: 10.1007/978-3-319-16522-6_2  0.6
2014 Sahdeo S, Wallace T, Hirakawa R, Knoflach F, Bertrand D, Maag H, Misner D, Tombaugh GC, Santarelli L, Brameld K, Milla ME, Button DC. Characterization of RO5126946, a Novel α7 nicotinic acetylcholine receptor-positive allosteric modulator. The Journal of Pharmacology and Experimental Therapeutics. 350: 455-68. PMID 24917542 DOI: 10.1124/jpet.113.210963  0.6
2014 Umbricht D, Alberati D, Martin-Facklam M, Borroni E, Youssef EA, Ostland M, Wallace TL, Knoflach F, Dorflinger E, Wettstein JG, Bausch A, Garibaldi G, Santarelli L. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. Jama Psychiatry. 71: 637-46. PMID 24696094 DOI: 10.1001/jamapsychiatry.2014.163  0.6
2014 Wu YJ, He H, Gao Q, Wu D, Bertekap R, Westphal RS, Lelas S, Newton A, Wallace T, Taber M, Davis C, Macor JE, Bronson J. Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor. Bioorganic & Medicinal Chemistry Letters. 24: 1611-4. PMID 24507922 DOI: 10.1016/j.bmcl.2014.01.036  0.6
2014 Huang M, Felix AR, Kwon S, Lowe D, Wallace T, Santarelli L, Meltzer HY. The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release. Psychopharmacology. 231: 2199-210. PMID 24317442 DOI: 10.1007/s00213-013-3373-5  0.6
2013 Wallace TL, Bertrand D. Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex. Biochemical Pharmacology. 85: 1713-20. PMID 23628449 DOI: 10.1016/j.bcp.2013.04.001  0.6
2013 Wu YJ, He H, Bertekap R, Westphal R, Lelas S, Newton A, Wallace T, Taber M, Davis C, Macor JE, Bronson J. Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression. Bioorganic & Medicinal Chemistry. 21: 2217-28. PMID 23477943 DOI: 10.1016/j.bmc.2013.02.010  0.6
2013 Wallace TL, Bertrand D. Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia. Expert Opinion On Therapeutic Targets. 17: 139-55. PMID 23231385 DOI: 10.1517/14728222.2013.736498  0.6
2013 Young JW, Jentsch JD, Bussey TJ, Wallace TL, Hutcheson DM. Consideration of species differences in developing novel molecules as cognition enhancers. Neuroscience and Biobehavioral Reviews. 37: 2181-93. PMID 23064177 DOI: 10.1016/j.neubiorev.2012.10.002  0.6
2013 Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, ... Wallace TL, et al. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Molecular Psychiatry. 18: 543-56. PMID 22641180 DOI: 10.1038/mp.2012.57  0.6
2012 Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velázquez-Sánchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, ... ... Wallace TL, et al. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biological Psychiatry. 72: 934-42. PMID 22705041 DOI: 10.1016/j.biopsych.2012.05.014  0.6
2011 Wallace TL, Porter RH. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochemical Pharmacology. 82: 891-903. PMID 21741954 DOI: 10.1016/j.bcp.2011.06.034  0.6
2011 Wallace TL, Ballard TM, Pouzet B, Riedel WJ, Wettstein JG. Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacology, Biochemistry, and Behavior. 99: 130-45. PMID 21463652 DOI: 10.1016/j.pbb.2011.03.022  0.6
2011 Rutten K, Wallace TL, Works M, Prickaerts J, Blokland A, Novak TJ, Santarelli L, Misner DL. Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-/-) mice. Neuropharmacology. 61: 138-47. PMID 21458469 DOI: 10.1016/j.neuropharm.2011.03.020  0.6
2008 Rutten K, Misner DL, Works M, Blokland A, Novak TJ, Santarelli L, Wallace TL. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice. The European Journal of Neuroscience. 28: 625-32. PMID 18702734 DOI: 10.1111/j.1460-9568.2008.06349.x  0.6
2005 Li YW, Fitzgerald L, Wong H, Lelas S, Zhang G, Lindner MD, Wallace T, McElroy J, Lodge NJ, Gilligan P, Zaczek R. The pharmacology of DMP696 and DMP904, non-peptidergic CRF1 receptor antagonists. Cns Drug Reviews. 11: 21-52. PMID 15867951  0.6
2004 Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biological Psychiatry. 56: 151-60. PMID 15271583 DOI: 10.1016/j.biopsych.2004.04.010  0.6
2003 Williams MT, Morford LL, Wood SL, Wallace TL, Fukumura M, Broening HW, Vorhees CV. Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse (New York, N.Y.). 48: 138-48. PMID 12645039 DOI: 10.1002/syn.10159  0.6
2003 Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Research. 968: 89-101. PMID 12644267 DOI: 10.1016/S0006-8993(02)04278-6  0.6
2003 Wallace TL, Vorhees CV, Zemlan FP, Gudelsky GA. Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience. 116: 1063-8. PMID 12617947 DOI: 10.1016/S0306-4522(02)00795-9  0.6
2002 Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 10883-90. PMID 12486182  0.6
2002 Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3663-72. PMID 11978842  0.6
2001 Wallace TL, Gudelsky GA, Vorhees CV. Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacology. 153: 321-6. PMID 11271404 DOI: 10.1007/s002130000578  0.6
2001 Wallace TL, Vorhees CV, Gudelsky GA. Effects of lubeluzole on the methamphetamine-induced increase in extracellular glutamate and the long-term depletion of striatal dopamine. Synapse (New York, N.Y.). 40: 95-101. PMID 11252020 DOI: 10.1002/syn.1030  0.48
2001 Roberts RC. Effect of chronic olanzapine treatment on striatal synaptic organization. Synapse (New York, N.Y.). 39: 8-15. PMID 11071704 DOI: 10.1002/1098-2396(20010101)39:1<8::AID-SYN2>3.0.CO;2-K  0.6
2001 Wallace TL, Gudelsky GA, Vorhees CV. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse (New York, N.Y.). 39: 1-7. PMID 11071703 DOI: 10.1002/1098-2396(20010101)39:1<1::AID-SYN1>3.0.CO;2-7  0.48
2000 Harold C, Wallace T, Friedman R, Gudelsky G, Yamamoto B. Methamphetamine selectively alters brain glutathione. European Journal of Pharmacology. 400: 99-102. PMID 10913590 DOI: 10.1016/S0014-2999(00)00392-7  0.6
1999 Wallace TL, Gudelsky GA, Vorhees CV. Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9141-8. PMID 10516332  0.6
Show low-probability matches.